Cite
HARVARD Citation
Richardson, P. et al. (2017). Lenalidomide in combination or alone as maintenance therapy following autologous stem cell transplant in patients with multiple myeloma: a review of options for and against. Expert opinion on pharmacotherapy. pp. 1975-1985. [Online].